Wang W C, Langston J W, Steen R G, Wynn L W, Mulhern R K, Wilimas J A, Kim F M, Figueroa R E
Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA.
J Pediatr. 1998 Jun;132(6):994-8. doi: 10.1016/s0022-3476(98)70397-x.
To determine whether abnormalities of the CNS are present in very young children with sickle cell anemia.
Thirty-nine children with hemoglobin SS between the ages of 7 and 48 months were examined with magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). No child had a history of clinical stroke, although 3 had a history of seizures (2 neonatal). Twenty-one patients underwent developmental testing with the Bayley or McCarthy Scales.
The overall prevalence of CNS abnormalities in asymptomatic children was 4 of 36 (11%, confidence interval 3, 26%). One patient had a silent infarct observed on MRI and a stenotic lesion on MRA; 3 other patients had stenotic lesions on MRA. The 3 patients who had a history of seizures all had lesions consistent with infarcts on MRI. Of the asymptomatic patients who had psychometric testing, 1 of 18 was developmentally delayed. One of 3 with a history of seizures had mild developmental delay.
Very young children with sickle cell anemia (and no history of clinical stroke) have infarction in the brain and/or stenosis of major cerebral arteries, similar to those reported in older children. These findings indicate a need for larger studies to define the incidence of CNS lesions in this age group and to determine the need for early therapeutic intervention to prevent CNS sequelae of sickle cell disease.
确定患有镰状细胞贫血的幼儿中枢神经系统(CNS)是否存在异常。
对39名年龄在7至48个月之间的血红蛋白SS型儿童进行了磁共振成像(MRI)和磁共振血管造影(MRA)检查。尽管有3名儿童有癫痫发作史(2名新生儿期发作),但无一例有临床中风史。21名患者接受了贝利或麦卡锡量表的发育测试。
无症状儿童中枢神经系统异常的总体患病率为36例中的4例(11%,置信区间3%,26%)。1例患者MRI显示无症状性梗死,MRA显示有狭窄病变;其他3例患者MRA显示有狭窄病变。有癫痫发作史的3例患者MRI上均有与梗死相符的病变。在接受心理测试的无症状患者中,18例中有1例发育迟缓。有癫痫发作史的3例中有1例有轻度发育迟缓。
患有镰状细胞贫血(且无临床中风史)的幼儿存在脑梗死和/或大脑主要动脉狭窄,与年龄较大儿童的情况类似。这些发现表明需要进行更大规模的研究,以确定该年龄组中枢神经系统病变的发生率,并确定是否需要早期治疗干预以预防镰状细胞病的中枢神经系统后遗症。